CacyBP/SIP protein promotes proliferation and G1/S transition of human pancreatic cancer cells
Citations Over TimeTop 19% of 2011 papers
Abstract
Abstract Calcyclin‐binding protein or Siah‐1‐interacting protein (CacyBP/SIP), a component of the ubiquitin‐mediated proteolysis, could participate in beta‐catenin degradation, which was found to be related to the malignant phenotypes of pancreatic cancer previously. However, the role of CacyBP/SIP itself in pancreatic cancer has not been investigated. In the present study, CacyBP/SIP expression was assayed and manipulated to reveal the potential mechanism in pancreatic cancer carcinogenesis. Here, we show that CacyBP/SIP is over‐expressed in pancreatic cancer cells. Down‐regulation of CacyBP/SIP by small interference RNA (siRNA) severely suppresses the proliferation and tumorigenesis in pancreatic cancer. G1/S transition arrest induced by inhibition of CacyBP/SIP is at least partly mediated by down‐regulation of Cyclin E and CDK2 as well as up‐regulation of p27 and Rb. Collectively, CacyBP/SIP as an enhancer of pancreatic cancer malignance might develop into another possible therapeutic target. Mol. Carcinog. © 2011 Wiley‐Liss, Inc.
Related Papers
- → The retinoblastoma protein is phosphorylated during specific phases of the cell cycle(1989)1,025 cited
- → Hypoxia induces p53 accumulation in the S-phase and accumulation of hypophosphorylated retinoblastoma protein in all cell cycle phases of human melanoma cells(1998)22 cited
- → The Ratio of Retinoblastoma (RB) to fos and RB to myc Expression during the Cell Cycle(1995)8 cited
- Cell death, cell growth and cell cycle regulation by the Retinoblastoma family(2017)